Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2025304619-A1 · Oct 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Idell Steven patents
Idell Steven is listed as an inventor on 24 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Idell Steven |
| Total patents | 24 |
| First publication | Dec 24, 2015 |
| Latest publication | Oct 2, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Inhibition of pulmonary fibrosis with nutlin-3A and peptides
US-12173089-B2 · Dec 24, 2024 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2024059736-A1 · Feb 22, 2024 · US
Inhibition of pulmonary fibrosis with nutlin-3A and peptides
US-11780879-B2 · Oct 10, 2023 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2023100467-A1 · Mar 30, 2023 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2022098239-A1 · Mar 31, 2022 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-11161875-B2 · Nov 2, 2021 · US
Polypeptide therapeutics and uses thereof
US-2021330741-A1 · Oct 28, 2021 · US
Compositions and methods for administration of an enzyme to a subject's airway
US-11033611-B2 · Jun 15, 2021 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2020165298-A1 · May 28, 2020 · US
Recent patents
Latest publications not already listed above.
Polypeptide therapeutics and uses thereof
US-2020164028-A1 · May 28, 2020 · US
Compositions and methods for administration of an enzyme to a subject's airway
US-2019255157-A1 · Aug 22, 2019 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-10377796-B2 · Aug 13, 2019 · US
Fibrinolytic potential: a test of pleural fluid to predict outcomes and guide dosing in fibrinolytic therapy
US-10175255-B2 · Jan 8, 2019 · US
Compositions and methods for administration of an enzyme to a subject's airway
US-2018140547-A1 · May 24, 2018 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2018086791-A1 · Mar 29, 2018 · US
Polypeptide therapeutics and uses thereof
US-2018050084-A1 · Feb 22, 2018 · US
Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
US-9808505-B2 · Nov 7, 2017 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2017253632-A1 · Sep 7, 2017 · US
Inhibition of pulmonary fibrosis with nutlin-3A and peptides
US-9630990-B2 · Apr 25, 2017 · US
Fibrinolytic Potential: A Test of Pleural Fluid to Predict Outcomes and Guide Dosing in Fibrinolytic Therapy
US-2016291043-A1 · Oct 6, 2016 · US
Compositions and methods for administration of an enzyme to a subject's airway
US-2016279209-A1 · Sep 29, 2016 · US
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
US-2016272678-A1 · Sep 22, 2016 · US
Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein c receptors (epcr)
US-2015366939-A1 · Dec 24, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Texas | 24 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P11/00 | 20 |
| A61K38/177 | 18 |
| A61K38/08 | 16 |
| A61P43/00 | 16 |
| A61K9/0019 | 15 |